Mark A Dickson

Mark A Dickson

UNVERIFIED PROFILE

Are you Mark A Dickson?   Register this Author

Register author
Mark A Dickson

Mark A Dickson

Publications by authors named "Mark A Dickson"

Are you Mark A Dickson?   Register this Author

42Publications

1738Reads

37Profile Views

Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.

JAMA Dermatol 2019 Mar;155(3):361-369

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.4940DOI Listing
March 2019

PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence.

Oncogene 2018 09 23;37(37):5066-5078. Epub 2018 May 23.

Departments of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0332-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137027PMC
September 2018

Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.

J Oncol Pract 2018 09 25;14(9):565-568. Epub 2018 Jul 25.

Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136896PMC
September 2018

ATRX is a regulator of therapy induced senescence in human cells.

Nat Commun 2017 08 30;8(1):386. Epub 2017 Aug 30.

The Louis V. Gerstner Graduate School of Biomedical Sciences, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-00540-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577318PMC
August 2017

Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Am J Dermatopathol 2017 Apr;39(4):304-309

*Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; †Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY; and ‡Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000000746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539502PMC
April 2017

Liposarcoma: Multimodality Management and Future Targeted Therapies.

Surg Oncol Clin N Am 2016 10 30;25(4):761-73. Epub 2016 Jul 30.

Sarcoma Disease Management Team, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Sarcoma Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010855PMC
October 2016

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

J Clin Oncol 2016 09 25;34(26):3166-74. Epub 2016 Jul 25.

Mrinal M. Gounder, William D. Tap, Mark A. Dickson, Mary Louise Keohan, Sandra P. D'Angelo, Mercedes Condy, Lanier Tanner, Joseph P. Erinjeri, and Francis H. Jasmine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Alona Zer, Samer Salah, Abha A. Gupta, Herbert H. Loong, Stephanie Baker, Kjirsten Nyquist-Schultz, and Albiruni Ryan Abdul Razak, Princess Margaret Cancer Center, Toronto, Ontario, Canada; and Sharon Friedlander, Robert Carlson, Thaddeus J. Unger, Jean-Richard Saint-Martin, Tami Rashal, Joel Ellis, Michael Kauffman, and Sharon Shacham, Karyopharm Therapeutics, Newton, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321073PMC
September 2016

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

Cancer Immunol Res 2016 05 29;4(5):383-9. Epub 2016 Feb 29.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241697PMC
May 2016

Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8.

Pediatr Blood Cancer 2016 Mar 15;63(3):392-7. Epub 2015 Oct 15.

St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984265PMC
March 2016

Reply to A. Indini et al.

J Clin Oncol 2016 Mar 19;34(9):1018-9. Epub 2016 Jan 19.

Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7007DOI Listing
March 2016

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.

J Clin Oncol 2015 Oct 17;33(28):3193-8. Epub 2015 Aug 17.

Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang, Kaitlin M. Woo, Katherine S. Panageas, Parisa Momtaz, Michael A. Postow, Margaret K. Callahan, Richard D. Carvajal, Mark A. Dickson, Sandra P. D'Angelo, Jedd D. Wolchok, and Paul B. Chapman, Memorial Sloan Kettering Cancer Center; Jedd D. Wolchok, Ludwig Institute for Cancer Research; and Michael A. Postow, Margaret K. Callahan, Richard D. Carvajal, Mark A. Dickson, Sandra P. D'Angelo, Jedd D. Wolchok, and Paul B. Chapman, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.8448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087335PMC
October 2015

Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications.

Am J Surg Pathol 2015 Jun;39(6):813-25

Departments of *Pathology †Surgery §Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center ‡Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000389DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431898PMC
June 2015

Systemic treatment options for radiation-associated sarcomas.

Authors:
Mark A Dickson

Curr Treat Options Oncol 2014 Sep;15(3):476-81

Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 300 E 66th St, New York, NY, 10065, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-014-0299-zDOI Listing
September 2014

Molecular pathways: CDK4 inhibitors for cancer therapy.

Authors:
Mark A Dickson

Clin Cancer Res 2014 Jul 2;20(13):3379-83. Epub 2014 May 2.

Author's Affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1551DOI Listing
July 2014

Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells.

Leuk Res Rep 2014 20;3(2):38-41. Epub 2014 May 20.

Departments of Medicine (M.A.D., E.B.P., S.C.J., R.J.B.) and Pathology (S.C.J., C.V.H.), Memorial Sloan-Kettering Cancer Center, New York, N.Y. 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2014.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050285PMC
June 2014

Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.

Int J Cancer 2013 Apr 21;132(7):1711-7. Epub 2012 Sep 21.

Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558545PMC
April 2013

A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors.

Clin Cancer Res 2011 Apr 21;17(8):2484-92. Epub 2011 Jan 21.

Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078945PMC
April 2011

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.

Cancer Chemother Pharmacol 2010 Nov 21;66(6):1113-21. Epub 2010 Feb 21.

Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1269-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957673PMC
November 2010

Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors.

Clin Cancer Res 2009 Dec 24;15(23):7405-11. Epub 2009 Nov 24.

Genitourinary Oncology Service, Department of Medicine, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-09-1502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787644PMC
December 2009